TTK Healthcare Q1: Profit Surge, Margin Expansion

TTK Healthcare Q1 FY26 Results Net Profit: ₹213M vs ₹130M (YoY) ⬆️ Revenue: ₹2.6B vs ₹2.3B (YoY) ⬆️ EBITDA: ₹147M vs ₹27M (YoY) ⬆️ EBITDA Margin: 5.7% vs 1.2% (YoY) ⬆️ 📊 Fundamentals & Ratios Revenue: ~₹9.5B Net Profit: ~₹0.6B Debt-to-Equity: ~0.3 P/E Ratio: ~20–22 ROE: ~14% Dividend Yield: ~1.5% 🏦 Projects Pharma growth initiatives Medical device expansion Consumer wellness products R&D investments Sustainability programs ⚠️ Risks Margin sustainability Competitive intensity Regulatory compliance Demand cyclicality Capex execution